Description of senior citizens with a diagnosis of bronchial asthma
Keywords:
ASTHMA, PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, AGEDAbstract
Background: asthma in the elderly is difficult to be diagnosed, due to the poor perception of air flow limitation, the acceptance of dyspnea as something common at an advanced age, diminished shape and physical activity, as well as the presence of comorbidities with other diseases or associated risk factors.
Objective: to describe the elderly patients with a diagnosis of bronchial asthma, attended to at the "Amalia Simoni" Provincial Medico-Chirurgical Hospital of Camagüey, during 2016.
Methods: a cross-sectional descriptive study was carried out with a sample of 62 senior citizens of the 60 to 79 age group, with a clinical and spirometric diagnosis of bronchial asthma, who visited the pulmonology and internal medicine departments of the aforementioned hospital and during the period herein declared.
Results: there was a prevalence of elderly patients of 60-69 years old (67,7 %) and of the female sex (61,3 %). There was a high index of radiological, electrocardiographic and echocardiographic alterations, coinciding with the frequency of other diseases with bronchial asthma in this population group. The comorbidities that predominated were smoking (93,5 %), chronic obstructive pulmonary disease (74,2 %), heart failure (72,6 %), hypertension (61,3 %) and diabetes mellitus (56 %).
Conclusions: the study described the sample of senior citizens diagnosed with bronchial asthma.
Downloads
References
Pedersen S E, Hyrd S S, Lemanske R F. Global strategy for the diagnosis and managemenent of asthma in children 5 years and younger. Pediatr Pulminol [revista en internet]. 2011 [citado 10 de abril 2017]; 46(1): 44-50 Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/ppul.21321/full.
OMS. Estrategia global para el manejo y la prevención del Asma; Asamblea de la GINA. 2010. Disponible en: http://blog.utp.edu.co/maternoinfantil/files/2010/08/GINA.pdf.
Arteaga Prado Y, Arencibia Díaz L, Gómez Guerra D B, Martínez Martínez A, Almora Carbonell C. Caracterización epidemiológica de la descompensación aguda del asma bronquial. Rev Ciencias Médicas [revista en internet]. 2013 [citado 10 de abril 2017]; 17(4): 94-104. Disponible en: http://www.revcmpinar. sld.cu/index.php/publicaciones/article/view/836.
Abramson MJ, Schatner RL, Sulaiman ND, Del Colle EA, Aroni R, Thien F. Accuracy of asthma and COPD diagnosis in Australian general practice: a mixed methods study. Prim Care Respir J [revista en internet]. 2012 [citado 10 de abril 2017]; 21: 167-73. Disponible en: http://www.nature.com/articles/pcrj2011103.
Sepúlveda R. Ha llegado el momento de pensar en calidad de la atención en Enfermedades Respiratorias: Time is coming. Revista chilena de enfermedades respiratorias [revista en internet]. 2016 [citado 10 de abril 2017]; 32(4): 215-16. Disponible en: http://www.scielo.cl/scielo.php?pid=S0717-7348201600040000 1&script=sci_arttext.
Boy R C, Pérez J H, Perea J A. Farmacología clínica de la teofilina en el tratamiento del asma. Revista de Medicina de la Universidad de Navarra [revista en internet]. 2016 [citado 10 de abril 2017]; 26(3): 39. Disponible en: http://www.unav.edu/publicaciones/revistas/index.php/revista-de-medicina/article/view/594 2.
MINSAP. Anuario estadístico de salud. Cuba 2015. Ministerio de salud pública. Dirección de registros médicos y de estadísticas de salud. La Habana. Cuba [en línea]. 2016 [citado 11 de enero 2017]. Disponible en: http://www.sld.cu/sitios/dne/.
Roche N, Colice G, Israel E, Martin R J, Dorinsky P M, Postma D S, Hillyer E V. Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2. Pulmonary Therapy [revista en internet]. 2016 [citado 10 de abril 2017]; 2(1): 73-89. Disponible en: http://link.springer.com/article/10.1007/s41030-016-0014-2.
Gruffydd-Jones K, Brusselle G, Jones R, Miravitlles M, Baldwin M, Stewart R, Price D. Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: in UK primary care: a real-world, retrospective, observational. Npj Primary Care Respiratory Medicine [revista en internet]. 2016 [citado 10 de abril 2017]; 26. Disponible en: http://search.proquest.com/openview/c21cba 8aa37297b01cbef8bdcb0577e8/1?pq-origsite=gscholar&cbl=2041920.
Zequi A A, Schivo M, Chan A, Albertson T E, Louie S. The Asthma-COPD overlap syndrome: a common clinical problem in the elderly. J allergy [revista en internet]. 2011 [citado 10 de abril 2017]; 2011(2011). Disponible en: https://www.hindawi.com/journals/ja/2011/861926/abs/.
Horak F, Doberer D, Eber E, Horak E, Pohl W, Riedler J, Studnicka M. Diagnosis and management of asthma–Statement on the 2015 GINA Guidelines. Wiener klinische Wochenschrift [revista en internet]. 2016 [citado 10 de abril 2017]; 128(15-16): 541-54. Disponible en: http://link.springer.com/article/10.100 7/s00508-016-1019-4.
Van Boven JF, Román-Rodríguez M, Palmer JF, Toledo-Pons N, Cosío BG, Soriano JB. Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life. CHEST Journal [revista en internet]. 2016 [citado 10 de abril 2017]; 149(4): 1011-20. Disponible en: http://journal.publications.chestnet.org/article. aspx?articleid=2480388.
Halpin DM, Kerkhof M, Soriano JB, Mikkelsen H, Price DB. Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy. Respiratory Research [revista en internet]. 2016 [citado 10 de abril 2017]; 17(1). Disponible en: https://respiratory-research.biomedcentral.com/ articles/10.1186/s12931-016-0433-5.
Sin D, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Wechsler ME. What is asthma−COPD overlap syndrome? Towards a consensus definition from a round table discussion. European Respiratory Journal [revista en internet]. 2016 [citado 10 de abril 2017]; 48(3): 664-73. Disponible en: http://erj.ersjournals.com/content/48/3/664.
Eid NS, O’Hagan A, Bickel S, Morton R, Jacobson S, Myers JA. Anti-inflammatory dosing of theophylline in the treatment of status asthmaticus in children. Journal of asthma and allergy [revista en internet]. 2016 [citado 10 de abril 2017]; 9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066866/.
Louie S, Selki AA, Schivo M, Chan AL, Yoneda KY, Avdalovic M, et al. The asthma-chonic obstructive pulmonary disease overlap symdrome pharmacotherapeutic considerations. Expert Rev clin pharmacol [revista en internet]. 2014 [citado 10 de abril 2017]; 6(2): 197-219. Disponible en: http://www.tandfonline. com/doi/abs/10.1586/ecp.13.2.
Miravitles M, Soler–Cataluna JJ, Cosio B, Izquierdo JL, Alcalle M, Soriano JB. Treatment of COPD by clinical phenotype: putting old evidence into clinical practice. Eur Respir J [revista en internet]. 2013 [citado 10 de abril 2017]; 41(6): 1252-6. Disponible en: http://erj.ersjournals.com/content/41/6/1252.
Miravitlles M, Soler-Cataluña JJ. GOLD in 2017: A View From the Spanish COPD Guidelines (GesCOPD). Archivos de Bronconeumología [revista en internet]. 2017 [citado 10 de abril 2017]; 53(3): 89-90. Disponible en: http://www.sciencedirect.com/science/article/pii/S1579212917300204.
Vogelmeier C F, Criner G J, Martinez F J, Anzueto A, Barnes P J, Bourbeau J, Frith, P. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report. Respirology [revista en internet]. 2017 [citado 10 de abril 2017]; 22(3): 575-601. Disponible en: http://onlinelibrary. wiley.com/doi/10.1111/resp.13012/full.
Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, Lund V. Positioning the Principles of Precision Medicine in Care Pathways for Allergic Rhinitis and Chronic Rhinosinusitis-A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy [revista en internet]. 2017 [citado 10 de abril 2017]; 72(9): 1297–1305. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/all.13162/full.
Chung KF, Wensel SE, Brozek JL. International ERS/ATS. Guidelines on definition. Evaluation and treatment of severe asthma. Eur respir j [revista en internet]. 2013 [citado 10 de abril 2017]; 43: 343-73. Disponible en: http://erj.ersjournals.com/content/44/5/1378.short.
Brocard Arencibia I, Proenza Fernández L, Guillén Garrido T, Tamayo Blanco FM. Tratamiento con Montelukast. Eficacia en adultos mayores Treatment with Montelukast. Effectiveness in elders. MULTIMED [revista en internet]. 2017 [citado 10 de abril 2017]; 19(4). Disponible en: http://www.revmultimed.sld. cu/index.php/mtm/article/view/372.
Burden A, Roche N, Miglio C, Hillyer E V, Postma D S, Herings R M, Price D B. An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma. Pragmatic and Observational Research [revista en internet]. 2017 [citado 10 de abril 2017]; 8(2017): 5. Disponible en: .https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367458/.
Roche N, Reddel HK, Agusti A, Eric D Bateman, Jerry A Krishnan, Richard J Martin, et al. Integrating real-life studies in the global therapeutic reseach framework. Lancet Respir Med [revista en internet]. 2013 [citado 10 de abril 2017]; 1(10): 29-e30. Disponible en: DOI: http://dx.doi.org/10.1016/S2213-2600(13)70199-1.
Downloads
Published
How to Cite
Issue
Section
License
This journal provides free and immediate access to its content under the principle that making research freely available to the public supports a greater exchange of global knowledge. This means that the authors transfer the copyright to the journal, so that copies and distribution of the contents can be made by any means, as long as the authors' acknowledgment is maintained. These terms are a reflection that the journal assumes copyright under Creative Commons licenses, specifically under a Creative Commons Attribution 4.0 International license.
Registration and submission of articles to the journal is free. The processing, including review, editing and publication, is completely free of charge.